vs
Side-by-side financial comparison of CARPENTER TECHNOLOGY CORP (CRS) and SELECT MEDICAL HOLDINGS CORP (SEM). Click either name above to swap in a different company.
SELECT MEDICAL HOLDINGS CORP is the larger business by last-quarter revenue ($1.4B vs $811.5M, roughly 1.8× CARPENTER TECHNOLOGY CORP). CARPENTER TECHNOLOGY CORP runs the higher net margin — 17.2% vs 4.5%, a 12.7% gap on every dollar of revenue. On growth, CARPENTER TECHNOLOGY CORP posted the faster year-over-year revenue change (11.6% vs 5.0%). Over the past eight quarters, SELECT MEDICAL HOLDINGS CORP's revenue compounded faster (5.3% CAGR vs 0.8%).
Carpenter Technology Corporation develops, manufactures, and distributes stainless steels and corrosion-resistant nickel, copper and titanium alloys as well as powdered alloys for 3D additive manufacturing. In fiscal year 2018, the company's revenues were derived from the aerospace and defense industry (55%), the industrial and consumer industry (17%), the medical industry (8%), the transportation industry (7%), the energy industry (7%), and the distribution industry (6%). The company's produ...
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
CRS vs SEM — Head-to-Head
Income Statement — Q3 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $811.5M | $1.4B |
| Net Profit | $139.6M | $63.8M |
| Gross Margin | 31.0% | — |
| Operating Margin | 23.0% | 6.9% |
| Net Margin | 17.2% | 4.5% |
| Revenue YoY | 11.6% | 5.0% |
| Net Profit YoY | 46.3% | -14.7% |
| EPS (diluted) | $2.77 | $0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $811.5M | $1.4B | ||
| Q4 25 | $728.0M | $1.4B | ||
| Q3 25 | $733.7M | $1.4B | ||
| Q2 25 | $755.6M | $1.3B | ||
| Q1 25 | $727.0M | $1.4B | ||
| Q4 24 | $676.9M | $1.3B | ||
| Q3 24 | $717.6M | $1.3B | ||
| Q2 24 | $798.7M | $1.3B |
| Q1 26 | $139.6M | $63.8M | ||
| Q4 25 | $105.3M | $20.2M | ||
| Q3 25 | $122.5M | $28.8M | ||
| Q2 25 | $111.7M | $40.6M | ||
| Q1 25 | $95.4M | $56.7M | ||
| Q4 24 | $84.1M | $-16.1M | ||
| Q3 24 | $84.8M | $55.6M | ||
| Q2 24 | $93.6M | $77.6M |
| Q1 26 | 31.0% | — | ||
| Q4 25 | 30.0% | — | ||
| Q3 25 | 29.5% | — | ||
| Q2 25 | 28.3% | — | ||
| Q1 25 | 27.6% | — | ||
| Q4 24 | 26.2% | — | ||
| Q3 24 | 24.6% | — | ||
| Q2 24 | 23.9% | — |
| Q1 26 | 23.0% | 6.9% | ||
| Q4 25 | 21.3% | 4.6% | ||
| Q3 25 | 20.9% | 5.4% | ||
| Q2 25 | 20.1% | 6.5% | ||
| Q1 25 | 19.0% | 8.3% | ||
| Q4 24 | 17.6% | 1.6% | ||
| Q3 24 | 15.8% | 4.3% | ||
| Q2 24 | 13.6% | 5.8% |
| Q1 26 | 17.2% | 4.5% | ||
| Q4 25 | 14.5% | 1.4% | ||
| Q3 25 | 16.7% | 2.1% | ||
| Q2 25 | 14.8% | 3.0% | ||
| Q1 25 | 13.1% | 4.2% | ||
| Q4 24 | 12.4% | -1.2% | ||
| Q3 24 | 11.8% | 4.4% | ||
| Q2 24 | 11.7% | 6.1% |
| Q1 26 | $2.77 | $0.35 | ||
| Q4 25 | $2.09 | $0.17 | ||
| Q3 25 | $2.43 | $0.23 | ||
| Q2 25 | $2.21 | $0.32 | ||
| Q1 25 | $1.88 | $0.44 | ||
| Q4 24 | $1.66 | $-0.12 | ||
| Q3 24 | $1.67 | $0.43 | ||
| Q2 24 | $1.85 | $0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $294.8M | $25.7M |
| Total DebtLower is stronger | $690.4M | $1.8B |
| Stockholders' EquityBook value | $2.1B | $2.1B |
| Total Assets | $3.7B | $6.0B |
| Debt / EquityLower = less leverage | 0.33× | 0.88× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $294.8M | $25.7M | ||
| Q4 25 | $231.9M | $26.5M | ||
| Q3 25 | $208.0M | $60.1M | ||
| Q2 25 | $315.5M | $52.3M | ||
| Q1 25 | $151.5M | $53.2M | ||
| Q4 24 | $162.1M | $59.7M | ||
| Q3 24 | $150.2M | $191.5M | ||
| Q2 24 | $199.1M | $111.2M |
| Q1 26 | $690.4M | $1.8B | ||
| Q4 25 | — | $1.8B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | — | $1.8B | ||
| Q1 25 | — | $1.8B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $3.1B | ||
| Q2 24 | — | $3.6B |
| Q1 26 | $2.1B | $2.1B | ||
| Q4 25 | $2.0B | $1.7B | ||
| Q3 25 | $1.9B | $1.7B | ||
| Q2 25 | $1.9B | $1.7B | ||
| Q1 25 | $1.8B | $1.7B | ||
| Q4 24 | $1.7B | $1.7B | ||
| Q3 24 | $1.7B | $1.9B | ||
| Q2 24 | $1.6B | $1.4B |
| Q1 26 | $3.7B | $6.0B | ||
| Q4 25 | $3.5B | $5.9B | ||
| Q3 25 | $3.4B | $5.7B | ||
| Q2 25 | $3.5B | $5.7B | ||
| Q1 25 | $3.4B | $5.7B | ||
| Q4 24 | $3.3B | $5.6B | ||
| Q3 24 | $3.3B | $8.0B | ||
| Q2 24 | $3.3B | $7.9B |
| Q1 26 | 0.33× | 0.88× | ||
| Q4 25 | — | 1.06× | ||
| Q3 25 | — | 1.03× | ||
| Q2 25 | — | 1.10× | ||
| Q1 25 | — | 1.03× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.62× | ||
| Q2 24 | — | 2.54× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CRS
| Aerospace and Defense | $435.6M | 54% |
| Surcharge revenue | $155.9M | 19% |
| Industrial and Consumer | $78.1M | 10% |
| Medical | $51.7M | 6% |
| Energy | $50.5M | 6% |
| Distribution | $20.4M | 3% |
| Transportation | $19.3M | 2% |
SEM
Segment breakdown not available.
